Definitive Contract W81XWH17C0184
Award Date
9/15/17
Potential Completion Date
2/14/20
Potential Value
$1M
Funding Federal Agency
Defense Health Agency
Contracting Federal Agency
Medical Command
Awardee
Hybrid Plastics, Incorporated
Ultimate Awardee
Not listed
NAICS Category
541712 - Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
PSC Category
AN91 - R&D- Medical: Other (Basic Research)
Set-Aside Type
Total Small Business
Federal Contract Vehicle
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Hattiesburg, MS 39401, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
SBIR Program Phase II Action
Primary Consortia Member
Not listed
Similar Awards
<p>This is a $100,000.00 Small Business Innovation Research (SBIR) Phase I contract awarded by the U.S. Department of Homeland Security (DHS), Countering Weapons of Mass Destruction office, to Polymerplus LLC, a for-profit limited liability company. The contract is a firm fixed-price definitive contract with an ultimate completion date of October 31, 2015. This SBIR Phase I award funds research and development efforts by the small business contractor.</p>
This is a Definitive Contract awarded by the Defense Health Agency (DHA) to Chromologic LLC, a small business contractor, under the Small Business Innovation Research (SBIR) Program. The contract, with a Firm Fixed Price of $999,912.00, is for the development of a "Self-Healing Elastomer for Medical Simulation & Training" as part of DHA's Medical R&D efforts. Chromologic, a Minority Owned, American Indian Owned, and Subcontinent Asian American Owned Limited Liability Company,...
The Defense Health Agency (DHA) awarded a $2,986,772.93 Firm Fixed Price contract to Perfusion Medical LLC, a small business biotechnology company, for IND-enabling studies of PM-208, a novel pre-hospital anti-shock therapeutic. This contract, which is part of the Small Business Innovation Research (SBIR) program Phase II, is set aside for small businesses. Perfusion Medical LLC specializes in developing innovative intravenous solutions for treating acute medical conditions such as septic shock,...
This is a $1,649,996.73 firm-fixed-price contract awarded by the Defense Health Agency (DHA) to Daxor Corporation, a self-certified small disadvantaged business, for Phase II of the Small Business Innovation Research (SBIR) program. The contract, with a period of performance from July 2023 to November 2025, is for research and development related to hemorrhage treatment and blood volume analysis technologies to support combat casualty care. This contract is a set-aside for small businesses and...
<p>This is a Phase I Small Business Innovation Research (SBIR) contract awarded by the Defense Health Agency (DHA) to Desicorp, Inc. for the development of a thermally stable whole blood product for transfusion. The contract has a firm fixed price of $249,957.36 and a completion date of January 17, 2021. As a Phase I SBIR award, this contract is focused on the initial research and feasibility exploration of the proposed technology. The contract was set aside for small businesses.</p>
<p>This is a $149,987.54 Firm Fixed Price contract awarded by the U.S. Army Medical Command (MEDCOM) to Nano Terra, Inc., a self-certified small disadvantaged business, for a SBIR Phase I research project. The award is for the "SBIR PHASE I DHP H161-010-0050" effort, which falls under the SBIR (Small Business Innovation Research) program. The contract has a performance period from August 15, 2016 to March 16, 2017 and is designated as a Total Small Business set-aside.</p>
This is a SBIR (Small Business Innovation Research) Phase II contract awarded by the Defense Health Agency to Innosense Corporation, a small disadvantaged minority-owned business. The $999,998.59 contract is for research and development work related to the SBIR program. SBIR Phase II contracts provide funding for further development and prototyping of innovative technologies that were initially explored in a Phase I award. The contract is a cost-plus-fixed-fee type, which is common for this type...
This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the Defense Health Agency (DHA) to Zymeron Corporation, a minority-owned small business located in Research Triangle Park, North Carolina. The $2,999,998.63 fixed-price contract is for the "Development for ShockDefender Against Hemorrhagic Shock," which supports the DHA's medical research and development efforts. The contract was set aside for small businesses and will be performed in Research Triangle...
This is a $99,363.00 firm fixed price purchase order awarded by the Defense agency to American Hyperform, Inc., a small disadvantaged business, under the SBIR Phase I program. The contract has a 6-month period of performance for R&D related to an "American Hyperform-R & D Collider Day" project. As an SBIR Phase I award, this contract represents the initial research and development stage of a technology that could potentially lead to further development under the SBIR program....
This is a firm fixed-price purchase order awarded by the Defense Health Agency (DHA) to Acatechol, Inc., a small business, for a Small Business Innovation Research (SBIR) Phase I research and development project. The contract, valued at $249,999.84, is for the development of a bioinspired chitosan-based hydrogel for neuroprotective treatment of traumatic brain injury. The project, titled "Bioinspired Chitosan-Based Hydrogels for Neuroprotective Treatment for Traumatic Brain Injury," is...